31 – 40 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Comprehensive genetic characterization of pediatric T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
(
- Contribution to journal › Letter
- 2012
-
Mark
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
(
- Contribution to journal › Article
-
Mark
Barnet i sjukvården
2012) p.113-124(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Etikrådet vid Barn- och ungdomssjukhuset i Lund
2012) p.9-20(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2011
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of imatinib on top of BFM-like chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL). the EsPhALL study
(
- Contribution to journal › Published meeting abstract
-
Mark
Experimental Stem-Cell Based Therapy in Pediatrics : A Fictional Case Study
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Selective Persistence of Distinct Stem/B Leukaemic Stem Cells In Childhood Acute Lymphoblastic Leukaemia In Clinical Remission
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All
(
- Contribution to journal › Published meeting abstract